Celltrion, Inc.
Celltrion, Inc. (South Korea) is linked to 1 FDA-registered manufacturing site. 2 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Celltrion, Inc.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/celltrion-inc
Overview
Celltrion, Inc. is a South Korean biopharmaceutical company specializing in the development, production, and commercialization of biosimilars and innovative biologics. It is known for its pioneering efforts in the monoclonal antibody sector, offering treatments in various therapeutic areas.
Therapeutic areas
Registered manufacturing sites (1)
Physical sites registered with the US FDA and resolved to Celltrion, Inc., with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
FDA compliance signals
2 FDA enforcement records linked to this company.
- 4832019-10-22
Air Supply
- warning_letter2018-01-29
FDA Warning Letter (drug product)
Is this Celltrion, Inc.?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.